source
- Moderna sees revenue bump from international COVID vaccine salesThe company is making up for a decline in U.S. vaccine sales with better results elsewhere, continuing a turnaround that’s vaulted its stock price in 2026.BioPharma Dive · 3mo ago↗ source
- Samsung Biologics workers begin five-day strike over wage disputesAfter holding a rally in April, Samsung Biologics union workers on Friday started a five-day strike over wage negotiations. Around 95% of the company's union members voted on the strike, with the ...Endpoints · 3mo ago↗ source
- Acelyrin founder Shao-Lee Lin emerges at Cue, as it becomes latest to license from ChinaCue Biopharma announced a reboot Thursday afternoon, bringing in notable biotech executive Shao-Lee Lin as well as a new allergy asset developed in Taiwan and mainland China. The Boston-based biote…